On Friday, September 20, 2024, a critical Congressional Briefing on kratom science was convened in the Cannon House Office Building, within the House Veterans Affairs Committee Hearing Room. This significant event brought together renowned scientists and legislators to discuss the latest research and implications of kratom, a plant increasingly recognized for its potential benefits but continually criticized by the FDA.
The briefing called upon members of Congress, the FDA, and the media to engage with the scientific community to foster a well-informed dialogue about kratom. It is imperative for stakeholders to watch the briefing recording to fully grasp the detailed discussions and findings presented.
The recording is available for viewing here
